Nova Patents
EP0343631A3

Preventing agent for human immunodeficiency virus infection comprising menfegol

Abstract

Preventing agent for a human immunodeficiency virus infection contains menfegol as an active ingredient. The preventing agent may be in the form of a foaming tablet, a jelly preparation, vaginal suppository, or ointment. A condom applied with the jelly preparation is also disclosed.

Term

Term ended

Projected expiry passed 24 May 2009, 17.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

Every citation, both ways

Citations
DocumentRelationOfficeCategoryCited during
EP0255902A1CitesEuropean Patent Office (EPO)YSearch report
EP0287204A2CitesEuropean Patent Office (EPO)YPSearch report
CONTRACEPTION, vol 30, no. 2, 1984, pages 135-141; A.J AMORTEGUI et al.: "The effect of chemical intravaginal contraceptives and betadine on Urea-plasma urealyticum"Non-patent––Search report
CONTRACEPTION, vol. 35, no. 2, february 1987, pages 101-110; H. YOUSSEF et al.: "A clinical trial of neo sampoon vaginal tablets and emko foam in Alexandria, Egypt"Non-patent––Search report
PATENT ABSTRACTS OF JAPAN, vol. 13, no. 238, (C-603)(3586), 5th June 1989; & JP-A-1 047 717 (BUHEI AKAHA) 22-08-1989Non-patent––Search report
KANSENSHOGAKU ZASSHI, vol. 63, no. 10, October 1989, pages 1178-1181; S. YAMAI et al.: "In vitro effect of menfegol on Neisseria gonorrhoeae"Non-patent––Search report
ANDROLOGIA, vol. 22, no. 3, May-June 1990, pages 291-296; S. OSHIO et al.: "Spermicidal activity of menfegol-coated condom"Non-patent––Search report